← Back to Dashboard

Leronlimab

CCR5 inhibition

2D Structure

Structure not available

3D Structure

Loading 3D structure...

Chemical Identifiers

ClinicalTrials.govPubMed

Clinical Development by Virus2

Human immunodeficiency virus 1
HIV-1
Target: Human CCR5
Phase 3
Preclinical
Phase 2
Phase 3
Approved
NCT03902522
Phase 2
Preclinical
Phase 2
Phase 3
Approved
NCT04343651